FDA Inspection 1281150 — Xiamen Kang Zhongyuan Biotechnology Co., Ltd.
The FDA completed an inspection of Xiamen Kang Zhongyuan Biotechnology Co., Ltd. on Aug 15, 2025 in Xiamen. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Aug 15, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Xiamen (China)